Sickle cell disease, blood clotting, and severity
Treatments studied
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study looks at how different types of sickle cell disease (SS, S/beta0, S/C) are linked to blood clotting and disease severity. It may help doctors better understand the condition and how to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 8 years old or older.
- You must have sickle cell disease with one of the types: SS, S/beta0, or S/C.
- You must not have had a blood transfusion or therapeutic phlebotomy in the last 3 months.
- You should not be in any other research study that could interfere with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
This study looks at a certain type of blood cell (megakaryocytes) in people with sickle cell disease. It aims to learn more about the disease and is only for patients followed at the Guadeloupe sickle cell center who are in a stable phase (no recent crisis or transfusion).
This trial looks at the cells that help make platelets (megakaryocytes) in people with sickle cell disease. By comparing these cells when you are feeling well and during a pain crisis or chest syndrome, researchers hope to learn more about the condition and find better treatments.
This study looks at differences in red blood cells and how likely they are to form clots in people with sickle cell disease. The goal is to better understand clot risk and what blood markers may predict it.
This study looks at how major organs like the brain, kidneys, heart, and liver are affected in adults with sickle cell disease, whether they've had a bone marrow transplant or gene therapy, or are continuing regular treatment. You'll get detailed tests that can help doctors understand the disease better, which may lead to improved care.
This study collects blood samples to learn more about sickle cell-related genetics and biology. You might benefit indirectly by helping researchers understand the condition, even though this is laboratory research rather than a medication trial.
Hear when a new Sickle Cell Disease (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.